retatrutide 0.5mg Syringe dose for : r/Retatrutide Retatrutide Pens now available** Retatrutide
Description
GLP-1 Market Share, By Drug Class, 2025 (%) The triple agonists (Pipeline) segment held a 3% share of the market in 2025 and is expected to grow at the fastest CAGR of 29.4% during the projection period
Cancel before your next prescribing cycle if you don't want to continue, and do so before the prescription is issued
The agency also sent a letter to a compounding pharmacy for making a variety of peptides in unsterile conditions
These are meaningfully different regulatory categories and should not be conflated when comparing your options
How well does it work
Common Insurance Hurdles For Patients For many patients, the biggest obstacle to accessing GLP-1s is their insurance coverage
